Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02381067 · ClinicalTrials.gov registry record · NA
A Prospective Study of NuCel® in Cervical Spine Fusion
A NA study, sponsored by NuTech Medical.
- Terminated
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT02381067 is a NA study that was terminated before completion, run by NuTech Medical. The registered enrollment target is 61 participants.
The verdict
NCT02381067, a NA study, was terminated before completion, sponsored by NuTech Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The study is intended to demonstrate that the NuCel® allograft is effective and safe in promoting bone growth and fusion rate when used in cervical fusion in patients with one, two or three-level diseases of the cervical spine.
Interventions
- OTHER NuCel with Allograft Bone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02381067
The ClinicalTrials.gov registry entry for NCT02381067 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NuTech Medical, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NuCel with Allograft Bone is the first listed.
NCT02381067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02381067 about?
NCT02381067 is a clinical study titled "A Prospective Study of NuCel® in Cervical Spine Fusion". The study is intended to demonstrate that the NuCel® allograft is effective and safe in promoting bone growth and fusion rate when used in cervical fusion in patients with one, two or three-level diseases of the cervical spine.
What is the current status of trial NCT02381067?
This trial is currently terminated. It is a NA study. The enrollment target is 61 participants. The study started on 2015-03. Estimated completion is 2016-12-15.
What interventions are being tested in trial NCT02381067?
The interventions under investigation include: NuCel with Allograft Bone (OTHER).
Who is sponsoring clinical trial NCT02381067?
This trial is sponsored by NuTech Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.